About
Faculty: Charles E. Geyer Jr., MD, FACP
Faculty: Komal Jhaveri, MD, FACP
Faculty: Komal Jhaveri, MD, FACP
This online educational activity equips clinicians with up-to-date, practice-changing insights from SABCS 2025. Experts review pivotal data across early-stage and metastatic breast cancer, including advances in HER2- and TROP2-directed ADCs, and discuss how these findings can meaningfully inform treatment selection. Participants will learn how to apply new evidence to expand therapeutic options, improve patient outcomes, and navigate emerging safety and quality of life considerations.